20240041089. A NEW POWDER COMPOSITION simplified abstract (LIW INNOVATION AB)
Contents
A NEW POWDER COMPOSITION
Organization Name
Inventor(s)
[[:Category:Johan Bj�rkholm of Ulricehamn (SE)|Johan Bj�rkholm of Ulricehamn (SE)]][[Category:Johan Bj�rkholm of Ulricehamn (SE)]]
[[:Category:Lars Bj�rkholm of Borås (SE)|Lars Bj�rkholm of Borås (SE)]][[Category:Lars Bj�rkholm of Borås (SE)]]
A NEW POWDER COMPOSITION - A simplified explanation of the abstract
This abstract first appeared for US patent application 20240041089 titled 'A NEW POWDER COMPOSITION
Simplified Explanation
The patent application discloses powder compositions with a pH of at least 6 for delivering an active agent to the nasal cavity. The active agent can be nicotine, tetrahydrocannabinol (THC), or ethanol. The compositions contain a filling agent of water-soluble and water-insoluble microcrystalline cellulose, a matrix forming agent, and have a defined brightness and particle size range. The application also includes products that incorporate these powder compositions and support particles to induce a desired property.
- The patent application describes powder compositions with a pH of at least 6 for nasal delivery of an active agent.
- The active agent can be nicotine, THC, or ethanol.
- The compositions contain water-soluble and water-insoluble microcrystalline cellulose as a filling agent.
- A matrix forming agent is also included in the compositions.
- The compositions have a defined brightness and particle size range.
- The patent application also covers products that incorporate these powder compositions and support particles to achieve a desired property.
Potential Applications:
- Nasal delivery of active agents such as nicotine, THC, or ethanol.
- Pharmaceutical industry for developing nasal drug delivery systems.
- Smoking cessation products.
- Medical cannabis products.
Problems Solved:
- Provides a pH-controlled powder composition for efficient delivery of active agents to the nasal cavity.
- Overcomes the limitations of traditional delivery methods for nicotine, THC, or ethanol.
- Enables precise control over the particle size and brightness of the compositions.
Benefits:
- Enhanced absorption and bioavailability of active agents through nasal delivery.
- Improved convenience and ease of use compared to other delivery methods.
- Customizable properties of the powder compositions for specific applications.
- Potential for targeted and localized drug delivery to the nasal cavity.
Original Abstract Submitted
disclosed are powder compositions with a ph of at least 6 for delivery of an active agent to the nasal cavity, wherein the active agent is selected from at least one of nicotine, tetrahydrocannabinol (thc) and ethanol. the compositions comprise a filling agent of water soluble and water insoluble microcrystalline cellulose and a matrix forming agent and have a defined brightness and particle size range. also disclosed are products including the powder compositions and support particles inducing a desired property to the product.